Every SEC Form 3/4/5 on record for this filer (CIK 1607737) — 5 issuers, 58 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | President & CEO | 2020-03-18 → 2026-06-05 | 25 | −$1M |
| DXCM | DEXCOM INC | Director | 2025-03-10 → 2026-06-01 | 5 | — |
| GOSS | Gossamer Bio, Inc. | Director · lapsed | 2019-02-07 → 2023-06-09 | 6 | — |
| TBPH | Theravance Biopharma, Inc. | SVP, Chief Financial Officer · lapsed | 2015-08-17 → 2018-11-21 | 18 | −$1M |
| CORT | CORCEPT THERAPEUTICS INC | Director · lapsed | 2016-06-28 → 2018-08-22 | 5 | $155,070 |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
5 of 5 issuers are covered and open a security page; the rest are on file here only.